Despite bold ambitions in the Life Sciences Vision and NHS 10-Year Plan, uptake of new medicines remains slow. Can industry, ...
AI is already playing a fundamental role in every stage of the drug discovery process – from ideation all the way through to ...
Dr John Snowden, Consultant Haematologist and Director of Blood and Marrow Transplant at Sheffield Teaching Hospitals, said: ...
Although many of the terms in a ‘nurse’ word cloud may hint at the broad job description (care, diligence, compassion etc), I ...
Of all the healthcare policies the government blasted out over the summer, one should have stood out for pharma. The NHS is edging towards one of the most radical reforms in its history: the creation ...
AC Immune SA has announced peer-reviewed results from its phase 1b/2a trial of two Tau-targeting active immunotherapies for early Alzheimer’s disease. The study compared ACI-35.030, developed with AC ...
Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...
BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...
Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of ...
Johnson & Johnson has announced a positive opinion from the CHMP recommending expanded marketing authorisation for TREMFYA ...
Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...
Nxera Pharma and Cancer Research UK have announced the first patient has been dosed in a phase 2a trial of HTL0039732, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback